Banks still lending money to pharmaceutical market
Fildas group of firms, controlled by Anca Vlad, is set to
refinance, in October, a 71m-euro loan contracted three years ago
from a syndicate made up of ten banks, with the documents to be
signed in the following period.
"Conditions are not different (compared with 2007 i.e.). We've
benefitted from a smooth restructuring. The major issue in
syndication is harmonising ten points of view," Anca Vlad told
Ziarul Financiar.
There is no information available about who will lend to the
company this year. Refinancing is operated over a five-year period
and its value is lower than the 80m-euro contracted in 2007 as the
difference has already been paid.
"This year, Fildas' strategy includes growth of its own retail
operations, namely through Catena pharmacies as opposed to
wholesale because of the non-payment risk. There have been a lot of
bankruptcies and insolvency cases lately. We're focusing on selling
through safe channels," said Mihai Drumea, financial manager of
Fildas.
In a press conference yesterday, Anca Vlad announced Catena
pharmacies have cut prices of around 700 products by 15-22%, a
campaign due to unfold over a 4-month period.